Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Financing announced on October 6, 2026.
Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) announced on October 6, 2026, that it has secured $5.6 million in financing. The investment was led by billionaire entrepreneur John Paul DeJoria.
The financing amount totals $5.6 million. The filing related to this financing can be found at https://www.sec.gov/Archives/edgar/data/1971532/000149315226045860/0001493152-26-045860-index.htm.
As of the latest available data, Telomir Pharmaceuticals has a free float of 36,904,642 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.